Stereospecificity and clinical potency of neuroleptics.
Crow
T J
TJ
Deakin
J W
JW
Johnstone
E C
EC
D000818:Animals; D014150:Antipsychotic Agents / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D011954:Receptors, Dopamine / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine